Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Arcus Biosciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 186
- 0 vs. Q1 2025
- Shares held
- 99.7M
- +2.51M (+2.6%) vs. Q1 2025
- Total value
- $811.5M
- +$48.2M (+6.3%) vs. Q1 2025
- New holders
- 26
- 84 more added
- Sold out
- 26
- 51 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 231 | $3.78B |
| Q1 2026 | 211 | $2.57B |
| Q4 2025 | 209 | $2.89B |
| Q3 2025 | 190 | $1.37B |
| Q2 2025 | 186 | $811.5M |
| Q1 2025 | 187 | $763.3M |
| Q4 2024 | 186 | $1.25B |
| Q3 2024 | 187 | $815.7M |
| Q2 2024 | 193 | $790.9M |
| Q1 2024 | 172 | $997.7M |
| Q4 2023 | 185 | $1.01B |
| Q3 2023 | 187 | $947.9M |
| Q2 2023 | 181 | $1.11B |
| Q1 2023 | 180 | $1.01B |
| Q4 2022 | 200 | $1.11B |
| Q3 2022 | 183 | $1.37B |
| Q2 2022 | 173 | $1.33B |
| Q1 2022 | 157 | $1.60B |
| Q4 2021 | 142 | $2.06B |
| Q3 2021 | 131 | $1.68B |
| Q2 2021 | 130 | $1.24B |
| Q1 2021 | 148 | $1.25B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Arcus Biosciences, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −16,985−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −14,200−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −13,922−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −13,025−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −12,065−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −10,452−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −10,396−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −8,500−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −3,721−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |